Nanotechnology—the study and application of extremely small things—has tremendous potential to revolutionize medicine, especially the treatment of cancers and other complex diseases that don’t respond well to conventional medications. Dr. Joy Wolfram and her team at the Mayo Clinic are at the forefront of this research, working to develop multi-functional nanoparticle-based cancer therapies. Joy likens these nanoparticles to tiny cars that can be loaded with several different drugs, navigated through the body, and then delivered directly to diseased tissues, thereby increasing therapeutic efficacy and reducing side effects. Joy’s vision is to develop innovative nanomedicines that bring the next generation of cancer treatments directly to the clinic.